TRxADE HEALTH, Inc.TRxADE HEALTH, Inc.TRxADE HEALTH, Inc.

TRxADE HEALTH, Inc.

No trades
See on Supercharts
Market capitalization
‪8.80 M‬USD
−9.97USD
‪−3.47 M‬USD
‪11.45 M‬USD
‪848.80 K‬
Beta (1Y)
0.32

About TRxADE HEALTH, Inc.

CEO
Surendra Ajjarapu
Headquarters
Lutz
Employees (FY)
34
Founded
2005
ISIN
US89846A4058
FIGI
BBG000RNLYM7
TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. It operates through the following segments: Trxade, Inc., CSP, Integra, and Other. The Trxade, Inc. segment is involved in web based pharmaceutical marketplace platform B2B sales. The CSP segment refers to community specialty pharmacy, LLC – Licensed retail pharmacy B2C sales. The Integra segment consists of Integra Pharma, LLC, Licensed wholesaler of brand, generic and non-drug products B2B sales. The Other segment consists of corporate overhead expense, Alliance Pharma Solutions, LLC, and Bonum Health, LLC. The company was founded by Suren Ajjarapu and Prashant Patel on July 15, 2005 and is headquartered in Lutz, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MEDS is 7.30 USD — it has decreased by 0.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TRxADE HEALTH, Inc. stocks are traded under the ticker MEDS.
TRxADE HEALTH, Inc. is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
MEDS earnings for the last quarter are −0.45 USD whereas the estimation was −0.30 USD which accounts for −50.00% surprise. Estimated earnings for the next quarter are −0.75 USD. See more details about TRxADE HEALTH, Inc. earnings.
TRxADE HEALTH, Inc. revenue for the last quarter amounts to ‪2.25 M‬ USD despite the estimated figure of ‪2.66 M‬ USD. In the next quarter revenue is expected to reach ‪2.06 M‬ USD.
Yes, you can track TRxADE HEALTH, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MEDS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRxADE HEALTH, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MEDS reached its all-time high on Aug 17, 2009 with the price of 80059.95 USD, and its all-time low was 3.69 USD and was reached on Feb 8, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 34.00 employees. See our rating of the largest employees — is TRxADE HEALTH, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TRxADE HEALTH, Inc. EBITDA is ‪−1.32 M‬ USD, and current EBITDA margin is −21.98%. See more stats in TRxADE HEALTH, Inc. financial statements.